In an uncertain, volatile time, companies must keep their nerve and keep investing, says Immelt.
Business leaders from across the country are gathering this October to dissect a little understood, but enormous part of the US economy — the middle market.
Counterfeit prescription pharmaceuticals are widely recognized as a growing public health risk and a serious concern to public health officials, private companies, and consumers. Learn more.
Counterfeit prescription pharmaceuticals are a growing trend, widely recognized as a public health risk and a serious concern to public health officials, private companies, and consumers. In this CNBC.com special report, we take an in-depth look at the world of counterfeit pharmaceuticals, from the dangers they pose and where they’re made, to what is being done to combat them.
Consumer confidence, Fed speakers and home price data are on deck for markets Tuesday, as traders keep their focus on the stream of headlines from Europe.
"No one ever made a dime panicking, but many people made gigantic amounts of money taking advantage of those who did."
If Apple’s manufacturing partner in China is indeed making fewer iPads, should you take developments as a big neon sign that says the economy is slowing? Not so fast.
JP Morgan’s Thomas Lee points out that 53% of stocks have a P/E ratio of less than 12. That’s the lowest level since 2008. Should you just go for it and buy?
Stocks successfully tested their summer lows Thursday, but they are likely to take another run at them, as investors remain fearful of recession and European banking crisis.
Stocks came off their worst levels, but still finished sharply lower Thursday in heavy-volume trading as a gloomy outlook from the Federal Reserve in addition to ongoing economic jitters fueled concerns of a recession.
What follows is a look at stocks in the S&P 1,500 displaying unusual volume in Thursday's trading session.
Amid the panic and selling in the market, Option Monster Jon Najarian tells us hit the buy button. Here's why.
Anticipating what companies will say in October about real-world activity, with the Fast Money crew.
Cramer and his researcher, Nicole Urken, discuss what moves investors should make now.
It’s not all about Greece and Europe – global slowdown worries are also clouding the situation for stocks.” – Remember that from yesterday morning? It’s clearly holding true again today.
Futures plunged sharply Thursday after the Federal Reserve warned of significant risks to the struggling economy and following a report that showed further contraction in China's manufacturing sector.
The Fed's gloomy words on the economy left the market with a sinking feeling that's likely to spill into Thursday. "The Fed sounded nervous," one strategist said.
Markets are expecting the Fed to unveil a modern day "Operation Twist," similar to a Federal Reserve program in the early 1960s. Fed watchers speculate on various degrees of easing, but they basically agree the Fed is about to unveil a program to buy longer dated Treasury securities in a bid to hold down interest rates.
CNBC.com looked at the top ten colleges and discovered which CEOs spent time there as underclassmen. Check out what we found.
The Fed in the week ahead is widely expected to pull the trigger on a new easing program, as the European debt crisis continues to boil.